[DEFA14A] Silexion Therapeutics Corp Additional Proxy Soliciting Materials

Rhea-AI Filing Summary

Silexion Therapeutics Corp (SLXN) filed a DEFA14A supplement to its previously issued definitive proxy statement for the 2025 annual general meeting (AGM). The only change disclosed is an updated shareholder record date: close of business on Tuesday, June 24, 2025, replacing the originally stated June 16, 2025. All other AGM details remain unchanged. The meeting will be held on July 7, 2025 at 9:00 a.m. ET / 4:00 p.m. Israel time at Meitar Law Offices in Ramat Gan, Israel, with an online attendance option that allows questions but does not permit remote voting. No financial metrics, earnings data, or transaction information were provided within this filing.

Insights

Proxy Governance Analyst

TL;DR: Minor administrative update; neutral governance impact.

The DEFA14A corrects the record date for Silexion’s 2025 AGM to June 24, 2025. Such adjustments are routine when timing differences arise between filing and mailing schedules. There is no change to meeting agenda, voting matters, or board recommendations. From a governance standpoint, the amendment simply ensures compliance with notice requirements under SEC rules and Israeli corporate law, preventing potential challenges to vote validity. No financial or strategic implications are signaled.

Risk & Compliance Specialist

TL;DR: Administrative correction mitigates potential procedural risk.

Updating the record date removes exposure to shareholder disputes over eligibility and aligns the proxy with statutory notice periods. Because the correction is timely—18 days before the AGM—it should not delay the meeting or affect quorum. The absence of other revisions indicates stable governance processes. Overall impact on valuation, liquidity, and risk profile is negligible.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

Filed by the Registrant ☒

Filed by a Party other than the Registrant ☐

Check the appropriate box:

☐ Preliminary Proxy Statement

☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

☐ Definitive Proxy Statement

☒ Definitive Additional Materials

☐ Soliciting Material under §240.14a-12

SILEXION THERAPEUTICS CORP

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

☒ No fee required.

☐ Fee paid previously with preliminary materials.

☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

On June 16, 2025 Silexion Therapeutics Corp, or Silexion, filed with the Securities and Exchange Commission the definitive proxy materials for its upcoming 2025 annual general meeting, or the meeting, to be held on July 7, 2025 at 9:00 a.m., Eastern time/ 4:00 p.m. local (Israel) time, on July 7, 2025 at the offices of our external legal counsel, Meitar Law Offices, 16 Abba Hillel Road, 10th floor, Ramat Gan, Israel 5250608. The 2025 annual general meeting may also be attended virtually over the internet. You will be able to attend, and submit your questions during (but not speak at or vote at), the meeting online by visiting https://www.cstproxy.com/silexion/2025, or by calling 1-800-450-7155 (toll-free, within the U.S. and Canada) or +1 857-999-9155 (outside of the U.S. and Canada, standard rates apply), conference ID: 9030147#.

This supplement to the definitive proxy statement for the meeting is being filed to inform shareholders that the record date of shareholders entitled to notice of, and to vote at, the meeting has been updated to the close of business on Tuesday, June 24, 2025 (not Monday, June 16, 2025, as had been indicated in the originally-filed definitive proxy statement). All other information related to the meeting remains as it appeared in the originally-filed definitive proxy statement.

FAQ

What is the new record date for Silexion (SLXN) shareholders?

June 24, 2025 at the close of business.

Has the 2025 annual meeting date for SLXN changed?

No. It remains July 7, 2025 at 9:00 a.m. ET / 4:00 p.m. Israel time.

Where will the Silexion AGM be held?

At Meitar Law Offices, 16 Abba Hillel Road, 10th floor, Ramat Gan, Israel, with an online attendance option.

Can shareholders vote online at the SLXN 2025 AGM?

The virtual platform allows questions only; shareholders cannot speak or vote online.

Does the DEFA14A include any financial updates?

No. It solely corrects the shareholder record date; no financial data is provided.